ArticleProceedings of the National Academy of Sciences of the United States of America2013

Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1).

Michael J Fuller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.